The expression of murine double minute 2 is a favorable prognostic marker in esophageal squamous cell carcinoma without p53 protein accumulation

[1] Cahilly-Snyder L(1987)Molecular analysis and chromosomal mapping of amplified genes isolated from a transformed mouse 3T3 cell line Somat Cell Mol Genet 13 235-44

[2] Yang-Feng T(1991)Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line EMBO J 10 1565-9

[3] Francke U(1992)Amplification of a gene encoding a p53-associated protein in human sarcomas Nature 358 2353-60

[4] George DL(1994)Physical and functional interaction between wild-type p53 and mdm2 proteins Mol Cell Biol 14 1171-8

[5] Fakharzadeh SS(1993)Identification and characterization of multiple mdm-2 proteins and mdm-2-p53 protein complexes Oncogene 8 2353-60

[6] Truso SP(1993)Correlation of p53 mutations with epidermal growth factor receptor overexpression and absence of MDM-2 amplification in human esophageal carcinomas Mol Carcinog 8 306-11

[7] George DL(1997)Genetic alterations in patients with esophageal cancer with short- and long-term survival rates after curative esophagectomy Ann Surg 226 162-8

[8] Olinr JD(1998)Significance of retinoblastoma and mdm2 gene expression as prognostic markers for soft-tissue sarcoma Langenbecks Arch Surg 383 99-103

[9] Kinzler KW(1997)Clinicopathologic significance of the expression of mutated p53 protein and the proliferative activity of cancer cells in patients with esophageal squamous cell carcinoma J Am Coll Surg 185 398-403

[10] Meltzer PS(1995)MDM2 gene amplification in bone and soft-tissue tumors: association with tumor progression in differentiated adipose-tissue tumors Int J Cancer 64 342-6

[1] Cahilly-Snyder L(1987)Molecular analysis and chromosomal mapping of amplified genes isolated from a transformed mouse 3T3 cell line Somat Cell Mol Genet 13 235-44

[2] Yang-Feng T(1991)Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line EMBO J 10 1565-9

[3] Francke U(1992)Amplification of a gene encoding a p53-associated protein in human sarcomas Nature 358 2353-60

[4] George DL(1994)Physical and functional interaction between wild-type p53 and mdm2 proteins Mol Cell Biol 14 1171-8

[5] Fakharzadeh SS(1993)Identification and characterization of multiple mdm-2 proteins and mdm-2-p53 protein complexes Oncogene 8 2353-60

[6] Truso SP(1993)Correlation of p53 mutations with epidermal growth factor receptor overexpression and absence of MDM-2 amplification in human esophageal carcinomas Mol Carcinog 8 306-11

[7] George DL(1997)Genetic alterations in patients with esophageal cancer with short- and long-term survival rates after curative esophagectomy Ann Surg 226 162-8

[8] Olinr JD(1998)Significance of retinoblastoma and mdm2 gene expression as prognostic markers for soft-tissue sarcoma Langenbecks Arch Surg 383 99-103

[9] Kinzler KW(1997)Clinicopathologic significance of the expression of mutated p53 protein and the proliferative activity of cancer cells in patients with esophageal squamous cell carcinoma J Am Coll Surg 185 398-403

[10] Meltzer PS(1995)MDM2 gene amplification in bone and soft-tissue tumors: association with tumor progression in differentiated adipose-tissue tumors Int J Cancer 64 342-6